• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Robert F. Kennedy Jr.

Open door symbolizing exit
Favicon Fierce Pharma

CDER chief Høeg and CBER's Szarama exiting FDA posts

With the ink barely dry on outgoing commissioner Marty Makary’s resignation, more top regulators are heading for the exit at the FDA.
Fraiser Kansteiner , Darren Incorvaia May 15, 2026 1:44pm
Martin Makary FDA Senate HELP confirmation
Favicon Fierce Pharma

FDA's embattled Marty Makary steps down as commissioner

May 12, 2026 2:30pm
An artists concept of chains of amino acides called peptides which together make up polypeptides or proteins
Favicon Fierce Pharma

FDA advisory committee to discuss action on unapproved peptides

Apr 15, 2026 5:15pm
Signage for the Department of Health and Human Services HHS headquarters is seen on April 02 2025 in Washington DC
Favicon Fierce Healthcare

States' lawsuit against RFK Jr.'s HHS overhaul moves forward

Apr 9, 2026 7:30am
FDA
Favicon Fierce Pharma

FDA approves leucovorin without clinical trial—but not for autism

Mar 10, 2026 9:00am
Albert Bourla Pfizer CEO Bourla
Favicon Fierce Pharma

Pfizer CEO Albert Bourla levels criticism of CBER's Vinay Prasad

Mar 3, 2026 4:58pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings